Cargando…
The Oncopig Cancer Model as a Complementary Tool for Phenotypic Drug Discovery
The screening of potential therapeutic compounds using phenotypic drug discovery (PDD) is being embraced once again by researchers and pharmaceutical companies as an approach to enhance the development of new effective therapeutics. Before the genomics and molecular biology era and the consecutive e...
Autores principales: | Segatto, Natalia V., Remião, Mariana H., Schachtschneider, Kyle M., Seixas, Fabiana K., Schook, Lawrence B., Collares, Tiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723300/ https://www.ncbi.nlm.nih.gov/pubmed/29259556 http://dx.doi.org/10.3389/fphar.2017.00894 |
Ejemplares similares
-
The Potential of Nanotechnology in Medically Assisted Reproduction
por: Remião, Mariana H., et al.
Publicado: (2018) -
Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas
por: Schachtschneider, Kyle M., et al.
Publicado: (2017) -
The Oncopig as an Emerging Model to Investigate Copper Regulation in Cancer
por: Carlson, Alyssa L., et al.
Publicado: (2022) -
The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform
por: Schachtschneider, Kyle M., et al.
Publicado: (2017) -
The Melding of Drug Screening Platforms for Melanoma
por: Couto, Gabriela Klein, et al.
Publicado: (2019)